Literature DB >> 1546895

Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism.

G M Doherty1, J L Doppman, D L Miller, M S Gee, S J Marx, A M Spiegel, G D Aurbach, H I Pass, M F Brennan, J A Norton.   

Abstract

Persistent primary hyperparathyroidism due to mediastinal parathyroid adenoma was effectively treated by either angiographic ablation or median sternotomy in this study of 49 patients managed at the National Institutes of Health since 1977. Each patient presented here with symptomatic persistent primary hyperparathyroidism after failed initial surgical procedures done at other institutions. Each patient underwent extensive parathyroid localization procedures, including selective angiography, and most had a parathyroid adenoma localized to the mediastinum. Angiographic ablation, the deliberate injection of large doses of contrast material into the artery that selectively perfuses the adenoma, was initially successful in 22 of 30 procedures (73%) in 27 patients. Long-term control of persistent primary hyperparathyroidism was achieved in 17 of 27 patients (63%) by angiographic ablation. Each unsuccessful ablation could be easily salvaged by surgical resection. Surgical resection of the parathyroid adenoma by median sternotomy achieved immediate success in 24 of 24 procedures (p2 less than 0.02 versus ablation), and long-term cure in 23 of 23 evaluable patients (p2 less than 0.001 versus ablation). However, ablation did have benefits for the patients in whom it was successfully performed. It was associated with a significantly shorter hospital stay (median, 6 days versus 9 days for sternotomy, p2 less than 0.003), much less pain, and easier recuperation. Complications of each procedure were transient and similar in both groups. Operative resection is the most effective single means to eradicate mediastinal parathyroid adenoma; however, angiographic ablation can provide similar long-term control of hyperparathyroidism in 63% of patients with less pain and shorter convalescence than that seen in patients after median sternotomy. Our results suggest that angiographic ablation should be attempted as the initial procedure for patients with persistent primary hyperparathyroidism caused by an angiographically identified mediastinal parathyroid adenoma. Operation can be reserved for those who fail ablation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546895      PMCID: PMC1242395          DOI: 10.1097/00000658-199202000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Reoperation for persistent and recurrent hyperparathyroidism.

Authors:  M F Brennan; J A Norton
Journal:  Ann Surg       Date:  1985-01       Impact factor: 12.969

2.  Transplantation of the parathyroid glands: current status.

Authors:  S A Wells; A J Ross; J K Dale; R S Gray
Journal:  Surg Clin North Am       Date:  1979-02       Impact factor: 2.741

3.  Localization of parathyroid adenomas in patients who have undergone surgery. Part I. Noninvasive imaging methods.

Authors:  D L Miller; J L Doppman; T H Shawker; A G Krudy; J A Norton; J J Vucich; K A Morrish; S J Marx; A M Spiegel; G D Aurbach
Journal:  Radiology       Date:  1987-01       Impact factor: 11.105

4.  Localizing studies in patients with persistent or recurrent hyperparathyroidism.

Authors:  K E Levin; G A Gooding; M Okerlund; C B Higgins; D Norman; T H Newton; Q Y Duh; C D Arnaud; A E Siperstein; Q H Zeng
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

5.  The use of iodinated contrast agents to ablate organs: experimental studies and histopathology.

Authors:  J L Doppman; M Popovsky; M Girton
Journal:  Radiology       Date:  1981-02       Impact factor: 11.105

Review 6.  Parathyroid localization, three-dimensional modeling, and percutaneous ablation techniques.

Authors:  H Eisenberg; J Pallotta; B Sacks; A S Brickman
Journal:  Endocrinol Metab Clin North Am       Date:  1989-09       Impact factor: 4.741

7.  Treatment of hyperparathyroidism by percutaneous embolization of a mediastinal adenoma.

Authors:  J L Doppman; S J Marx; A M Spiegel; L E Mallette; D R Wolfe; G D Aurbach; G Geelhoed
Journal:  Radiology       Date:  1975-04       Impact factor: 11.105

8.  Angiographic ablation of parathyroid adenomas: lessons from a 10-year experience.

Authors:  D L Miller; J L Doppman; R Chang; J T Simmons; T J O'Leary; J A Norton; A M Spiegel; S J Marx; G D Aurbach
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

9.  Angiographic ablation of parathyroid adenomas.

Authors:  J L Doppman; E M Brown; M F Brennan; A Spiegel; S J Marx; G D Aurbach
Journal:  Radiology       Date:  1979-03       Impact factor: 11.105

10.  Incidence of hypercalcemia and malignant neoplasm.

Authors:  M E Burt; M F Brennan
Journal:  Arch Surg       Date:  1980-06
View more
  12 in total

1.  Controversies and advances in primary hyperparathyroidism.

Authors:  J A Norton
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

2.  Partial median sternotomy: an attractive approach to mediastinal parathyroid disease.

Authors:  Jason S Gold; Patricia I Donovan; Robert Udelsman
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

3.  Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism.

Authors:  Yodphat Krausz; Lise Bettman; Luda Guralnik; Galina Yosilevsky; Zohar Keidar; Rachel Bar-Shalom; Einat Even-Sapir; Roland Chisin; Ora Israel
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

4.  The results of surgery for mediastinal parathyroid tumors: a comparative study of 63 patients.

Authors:  Maurizio Iacobone; Isabella Mondi; Giovanni Viel; Marilisa Citton; Saveria Tropea; Mauro Frego; Gennaro Favia
Journal:  Langenbecks Arch Surg       Date:  2010-07-10       Impact factor: 3.445

5.  Thoracoscopic removal of mediastinal parathyroid lesions: selection of surgical approach and pitfalls of preoperative and intraoperative localization.

Authors:  Masatoshi Iihara; Rumi Suzuki; Akiko Kawamata; Kiyomi Horiuchi; Takahiro Okamoto
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

6.  Ectopic Parathyroid Adenoma Presenting as a Mediastinal Mass.

Authors:  Aneesha Vaidya; Mangala Gouri; H M Sudha; Vijaya Mysorekar; Avinash Balekudura
Journal:  J Clin Diagn Res       Date:  2017-05-01

7.  Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structures.

Authors:  Teresa J Chan; Steven K Libutti; J Andrea McCart; Clara Chen; Anjum Khan; Monica K Skarulis; Lee S Weinstein; John L Doppman; Stephen J Marx; H Richard Alexander
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

8.  A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma.

Authors:  N Jaskowiak; J A Norton; H R Alexander; J L Doppman; T Shawker; M Skarulis; S Marx; A Spiegel; D L Fraker
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

Review 9.  Thoracoscopic removal of mediastinal hyperfunctioning parathyroid glands: personal experience and review of the literature.

Authors:  P F Alesina; D Moka; J Mahlstedt; M K Walz
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

Review 10.  Mediastinal parathyroid adenomas and their surgical implications.

Authors:  Jesse Hu; K Y Ngiam; R Parameswaran
Journal:  Ann R Coll Surg Engl       Date:  2015-05       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.